New research suggests that depression could be treated with anti-inflammatory medicine

12.10.2017 - Addiction, Mental health, Therapies

Around one in 13 people in Britain suffers from anxiety or depression. Last year the NHS issued 64.7 million prescriptions for antidepressants – an all-time high – the most recent annual data from NHS Digital showed. That was 3.7m more than the 61m items dispensed during 2015.

Current treatment is largely centred around restoring mood-boosting chemicals in the brain, such as serotonin, but a recent article in the Telegraph newspaper pointed out that experts now think an overactive immune system triggers inflammation throughout the entire body, sparking feelings of hopelessness, unhappiness and fatigue. Furthermore, recent studies have shown that there is a link between a group of specific anti-inflammatory drugs and depression may shed light on the role that inflammation plays in the mental health condition.

This research again demonstrates how we should look beyond the mere symptoms of depression and treat the client as a whole. The mind and body cannot be separated, there is a real mechanistic connection between the mind, the nervous system and the immune system. Dr. Antoinette Sarasin Gianduzzo, Director of Biomolecular Restoration, Nutrition and Lifestyle at The Kusnacht Practice, commented: “This research is in-line with our approach to treating depression. One of the main goals of our Biomolecular Restoration (Bio–R) programme, which is a crucial part of our treatment concept, is to reduce inflammation in the body. For many patients it is a relief to have alternatives to conventional psychopharmacological agents. However, this is not to dismiss the effects of psychopharmacological agents – they are needed and do good when applied as part of a holistic treatment programme.”